Blood cancer Clinical Trials in La Jolla, CA
As of July 2026, 17 paid clinical trials are recruiting for Blood cancer in La Jolla, California. Blood cancer trials investigate CAR-T cell therapies, bispecific antibodies, BTK and BCL-2 inhibitors, and novel combinations across leukemias, lymphomas, myeloma, and myelodysplastic syndromes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
17 clinical trials for Blood cancer
·Clear filters·↓ Download CSVA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Elranatamab in Relapsed/Refractory Multiple Myeloma
About research studies in La Jolla
La Jolla has approximately 532 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in La Jolla
Researchers run research studies in La Jolla, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UC San Diego Moores Cancer Center | Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm, Stage IVB Prostate Cancer AJCC v8 | 84 |
| University of California San Diego | Amyotrophic Lateral Sclerosis, Cancer, Colorectal Cancer | 59 |
| University of California, San Diego | Prostate Cancer, Breast Cancer, Danon Disease | 50 |
| UC San Diego | Amyotrophic Lateral Sclerosis, Aortic Aneurysm, Abdominal, Becker Muscular Dystrophy | 17 |
| Scripps Health | Aortic Insufficiency, Aortic Regurgitation, Aortic Valve Insufficiency | 12 |
| UCSD Moores Cancer Center | Cancer, CRC, Colon Cancer | 11 |
| UC San Diego Health | Heart Failure, Ventricular Fibrillation, Central Nervous System Lymphoma | 9 |
| Altman Clinical and Translational Research Institute | Chronic Low-back Pain, Complex Regional Pain Syndrome, Healthy Participants Study | 6 |
| UCSD | Advanced/Metastatic Solid Tumors, Bipolar Disorder, Colorectal Cancer | 6 |
| University of California San Diego Moores Cancer Center | Advanced Solid Tumor, Cervical Cancer, Metastatic Castration-resistant Prostate Cancer | 6 |
| Clinical Trial Site | ATTR Amyloidosis, Advanced Hepatocellular Carcinoma, High Cardiovascular Risk | 5 |
| Kadima Neuropsychiatry Institute | Major Depressive Disorder, Depression, Depressive Disorder, Treatment-Resistant | 5 |
| Scripps Clinic Torrey Pines | Carcinoma, Hepatocellular, Colitis, Ulcerative, Colorectal Cancer Metastatic | 5 |
| Scripps Green Hospital | Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia Refractory | 5 |
| Scripps Memorial Hospital | Acute Decompensated Heart Failure, Coronary Arterial Disease (CAD), Heart Failure - NYHA II - IV | 5 |
| Scripps Translational Science Institute | Coronary Artery Disease, Healthy, Heart Diseases | 5 |
| University of California San Diego Medical Center | Alzheimers Disease, Alzheimers Disease, Familial, Dementia | 5 |
| Moores Cancer Center | Neoplasm Metastasis, Advanced Breast Cancer, Advanced Ovarian Cancer | 4 |
| Shiley Center for Orthopaedic Research and Education at Scripps Clinic | Adult Spinal Deformity, Kyphosis, Scoliosis | 4 |
| University of California at San Diego | Carcinoma, Non-small-Cell Lung, Hemolytic Disease of the Fetus and Newborn, Metastatic Castration-resistant Prostate Neoplasms | 4 |
| University of California, San Diego Moores Cancer Center | Basal Cell Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | 4 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Neoplasms, Prostate, Tumours, Gynecological | 3 |
| Kaizen Brain Center | Agitation, Alzheimer Disease, Chronic Migraine | 3 |
| Scripps Memorial Hospital La Jolla | Aortic Valve Disease Mixed, Aortic Valve Regurgitation, Heart Failure | 3 |
| Scripps Whittier Diabetes Institute | Atherosclerotic Cardiovascular Disease (ASCVD), Diabetes Mellitus, Type 1, Elevated Lp(a) | 3 |
Active & Upcoming Studies in La Jolla (2026)
Recruiting trials in La Jolla grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (185 active studies)
- Signatera Assessment in Early-Stage Endometrial Cancer · Natera, Inc.
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Neurology & pain (43 active studies)
- Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery · University of California, San Diego
- Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers · Scripps Translational Science Institute
Cardiovascular (31 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF) · Medtronic Cardiac Ablation Solutions
Diabetes & metabolic (23 active studies)
- Time Restricted Eating in Patients With Microalbuminuria · Phase 1 · University of California, San Diego
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Mental health & behavior (13 active studies)
- Frontal Gamma Coherence Neurofeedback for Patients With Schizophrenia · BioSignal Solutions LLC
- RE104 Safety and Efficacy Study in Generalized Anxiety Disorder · Phase 2 · Reunion Neuroscience Inc
HIV / STI (8 active studies)
- Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- An mHealth Intervention to Improve HIV Prevention Service Engagement Among People Who Use Drugs · University of California, San Diego
Eye & vision (7 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants · Phase 4 · Neurotech Pharmaceuticals
Vaccines (4 active studies)
- Preparedness Through Respiratory Virus Epidemiology and Community Engagement · University of California, San Diego
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Pediatric (3 active studies)
- Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants · University of California, San Diego
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in La Jolla
- Breast Cancer (13 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Colorectal Cancer (11 active studies). Colorectal cancer trials explore novel chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors.
- Heart Failure (10 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Prostate Cancer (10 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Advanced Solid Tumor (9 active studies). Recruiting Advanced Solid Tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ovarian Cancer (9 active studies). Ovarian cancer research examines PARP inhibitors, maintenance therapies, and antibody-drug conjugates for recurrent and platinum-resistant disease.
Leading research sponsors in La Jolla
- University of California, San Diego
- National Cancer Institute (NCI)
- AstraZeneca
- NRG Oncology
- Scripps Translational Science Institute
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in La Jolla. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in La Jolla
Hipa.ai aggregates every recruiting study in La Jolla from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in La Jolla?
There are approximately 532 recruiting clinical trials in La Jolla, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in La Jolla pay participants?
Most recruiting trials in La Jolla compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in La Jolla?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in La Jolla?
The most common conditions under active study in La Jolla include Breast Cancer (13), Colorectal Cancer (11), Heart Failure (10), Prostate Cancer (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in La Jolla?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in La Jolla on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in La Jolla?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in La Jolla?
Recruiting research sites in La Jolla include UC San Diego Moores Cancer Center, University of California San Diego, University of California, San Diego, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in La Jolla right now?
The largest active categories in La Jolla are Cancer & tumors (185), Neurology & pain (43), Cardiovascular (31). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.